| Authors: |
Sørensen JA; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark., Naassan S; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark., Vestergaard C; Department of Dermatology, Aarhus University Hospital, Denmark., Rosenø NAL; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark., Johansen CB; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark., Egeberg A; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Thyssen JP; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Orfanos P; Novartis Pharma AG, Basel, Switzerland., Chapman-Rothe N; Novartis Pharma AG, Basel, Switzerland., Raftery T; Novartis Ireland Ltd., Dublin, Ireland., Thomsen SF; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Ali Z; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark. |
